Three Different Topically Applied Materials as Non-invasive Treatment of Sensitivity in Permanent Teeth With Molar Incisor Hypomineralization

NCT ID: NCT07056855

Last Updated: 2025-07-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-10

Study Completion Date

2025-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical study main goal is to investigate the effectiveness of nano hydroxy apatite crystal varnish and potassium nitrate gel as a non invasive approach in managing Dentin Hypersensitivity in MIH-affected teeth.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This randomized clinical trial study aims to investigate the effectiveness of nano-hydroxy apatite crystal varnish, and potassium nitrate gel compared to fluoride varnish, in reducing dentin hypersensitivity, improving a child's oral hygiene.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dentine Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The assessment of outcomes will be performed with two investigators other than the main investigator, who will not be aware of the type of the intervention carried out on the assessed child.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

8.6% nano-hydroxy apatite crystals varnish (Fygg's professional strength, Fygg, USA).

Intervention group (1)

Group Type EXPERIMENTAL

nano hydroxy apatite varnish Intervention (1)

Intervention Type DRUG

Fygg's professional strength, Fygg, USA

Potassium Nitrate (Ultradent UltraEZ Desensitizing Gel, Ultradent Inc., USA).

Intervention group (2)

Group Type EXPERIMENTAL

Potassium Nitrate Gel

Intervention Type DRUG

Ultradent UltraEZ Desensitizing Gel, Ultradent Inc., USA

5% fluoride varnish Control group

Group Type ACTIVE_COMPARATOR

Varnishes, Fluorid

Intervention Type DRUG

DentKist Charm Varnish 5% Sodium Fluoride Varnish

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nano hydroxy apatite varnish Intervention (1)

Fygg's professional strength, Fygg, USA

Intervention Type DRUG

Potassium Nitrate Gel

Ultradent UltraEZ Desensitizing Gel, Ultradent Inc., USA

Intervention Type DRUG

Varnishes, Fluorid

DentKist Charm Varnish 5% Sodium Fluoride Varnish

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Exclusion Criteria

Participants related criteria:

1. Children with severe behavioral or emotional disabilities.
2. Children who received analgesics within the last 24 hours before the procedure.
3. Patients who are using chlorhexidine-based gels or mouthwashes.

Tooth related criteria:

1. A tooth with signs and symptoms of irreversible pulpitis.
2. A tooth with signs and symptoms of necrotic pulp.
3. Sealing therapy or application of desensitizing agent on the MIH teeth within one month before participation in the study.
4. Presence of dental caries on the MIH-affected permanent tooth.
5. Presence of restoration(s) on MIH-affected permanent tooth.
Minimum Eligible Age

6 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mennat Allah Ashraf Abd Elsabour Abd Elkareem

Assistant Lecturer, Pediatric Dentistry Department, Ahram Canadian University. PhD student, Pediatric Dentistry and Dental Public Health Department, Cairo University. Affiliation: Cairo University

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mennat Allah A. A. Abd Elsabour, PhD student

Role: CONTACT

+201026022605

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1444

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

3Mixtatin and MTA Vital Pulpotomy in Primary Molars
NCT06478940 NOT_YET_RECRUITING PHASE1